Applying cWAS to breast cancer data, we found that blood CD8+ T cells may serve as the protective factor against breast cancer, i.e. high CD8+ T cell proportions lead to lower breast cancer risks and better prognostic condition. This evidence concerns the gene CD8A and breast carcinoma.